These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1279634)

  • 1. Intravenously infused substance P enhances basal and growth hormone (GH) releasing hormone-stimulated GH secretion in normal men.
    Coiro V; Volpi R; Capretti L; Speroni G; Bocchi R; Caffarri G; Colla R; Rossi G; Chiodera P
    Peptides; 1992; 13(4):843-6. PubMed ID: 1279634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of ACTH/cortisol and GH responses to intravenously-infused substance P in Parkinson's disease.
    Volpi R; Caffarra P; Scaglioni A; Saginario A; Maestri D; Vourna S; Vescovi PP; Chiodera P; Coiro V
    J Neural Transm Park Dis Dement Sect; 1993; 6(2):99-107. PubMed ID: 7509607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of ACTH/cortisol by intravenously infused substance P in normal men: inhibition by sodium valproate.
    Coiro V; Capretti L; Volpi R; Davoli C; Marcato A; Cavazzini U; Caffarri G; Rossi G; Chiodera P
    Neuroendocrinology; 1992 Oct; 56(4):459-63. PubMed ID: 1282218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteinizing hormone response to an intravenous infusion of substance P in normal men.
    Coiro V; Volpi R; Capretti L; Caiazza A; Marcato A; Bocchi R; Colla R; Rossi G; Chiodera P
    Metabolism; 1992 Jul; 41(7):689-91. PubMed ID: 1377769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
    Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation.
    DeBell WK; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1312-6. PubMed ID: 2026752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH.
    Vance ML; Kaiser DL; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1986 Mar; 62(3):591-4. PubMed ID: 3080467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenously infused substance P is unable to change basal and TRH-stimulated PRL secretion in normal men.
    Coiro V; Volpi R; Capretti L; Caiazza A; Caffarri G; Rossi G; Marchesi C; Chiodera P
    Horm Res; 1993; 39(1-2):73-6. PubMed ID: 7691703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
    Massoud AF; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of substance P in suppressing growth hormone release in the rat.
    Arisawa M; Snyder GD; De Palatis L; Ho RH; Xu RK; Pan G; McCann SM
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7290-4. PubMed ID: 2476817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men.
    Hartman ML; Farello G; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1378-84. PubMed ID: 1592884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults--a clinical research center study.
    Chapman IM; Hartman ML; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2874-80. PubMed ID: 8768844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment.
    Giustina A; Girelli A; Bossoni S; Legati F; Schettino M; Wehrenberg WB
    Metabolism; 1992 May; 41(5):548-51. PubMed ID: 1375312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
    Rosenthal SM; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intravenous, subcutaneous, and intranasal GH-RH analog, [Nle27]GHRH(1-29)-NH2, on growth hormone secretion in normal men: dose-response relationships.
    Vance ML; Evans WS; Kaiser DL; Burke RL; Rivier J; Vale W; Thorner MO
    Clin Pharmacol Ther; 1986 Dec; 40(6):627-33. PubMed ID: 3096623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man.
    Vance ML; Kaiser DL; Evans WS; Thorner MO; Furlanetto R; Rivier J; Vale W; Perisutti G; Frohman LA
    J Clin Endocrinol Metab; 1985 Feb; 60(2):370-5. PubMed ID: 3917460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
    Massoud AF; Hindmarsh PC; Matthews DR; Brook CG
    Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galanin reinstates the growth hormone response to repeated growth hormone-releasing hormone administration in man.
    Arvat E; Ghigo E; Nicolosi M; Boffano GM; Bellone J; Yin-Zhang W; Mazza E; Camanni F
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):347-50. PubMed ID: 1385023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.
    Webb CB; Vance ML; Thorner MO; Perisutti G; Thominet J; Rivier J; Vale W; Frohman LA
    J Clin Invest; 1984 Jul; 74(1):96-103. PubMed ID: 6429198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theophylline blunts the GH-response to growth hormone releasing hormone in normal subjects.
    Losa M; Huss R; König A; Müller OA; von Werder K
    Acta Endocrinol (Copenh); 1986 Aug; 112(4):473-80. PubMed ID: 3092529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.